Physician profile
Jacob Paul
NPI 1831798685
$684.29
in general payments reported to CMS, 2019-2025
9 companies · $33.47 in 2025
The $33.47 reported for 2025 was less than what a typical Critical Care Medicine (Nurse Practitioner) provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $379 · 2022: $124 · 2023: $147 · 2025: $33.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $357.27 | 2021-2025 | Impella |
| Smith+Nephew, INC. | $124.35 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.83 | 2021 | |
| Grifols USA, LLC | $39.73 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.18 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.90 | 2021 | |
| Genzyme Corporation | $16.37 | 2021 | |
| Abbott Laboratories | $16.17 | 2023 | 2nd Gen Centrimag Primary Console |
| Mylan Specialty L.P. | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.